List of BioVersys AG patents

List of BioVersys AG patents

List of Clarus Therapeutics patents

List of Leeo patents

List of Cryocor patents

List of companies in OIG Oracles Investment Group's investment portfolio

List of awards received by Roy Keane

Patents where

Current Assignee

Name

is

BioVersys AG

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11098047 Antimicrobials and methods of making and using same	Patent 11098047 was granted and assigned to BioVersys AG on August, 2021 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	11098047	August 24, 2021
	‌ US Patent 10947237 Antimicrobial compounds and methods of making and using the same	Patent 10947237 was granted and assigned to BioVersys AG on March, 2021 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	10947237	March 16, 2021
	‌ US Patent 9682079 Composition for treatment of pathogens that are resistant to tetracyclines	Patent 9682079 was granted and assigned to BioVersys AG on June, 2017 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	9682079	June 20, 2017
	‌ US Patent 11344537 Rifabutin treatment methods, uses, and compositions	Patent 11344537 was granted and assigned to BioVersys AG on May, 2022 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	11344537	May 31, 2022
	‌ US Patent 11207305 Antibiotic combination therapies	Patent 11207305 was granted and assigned to BioVersys AG on December, 2021 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	11207305	December 28, 2021
	‌ US Patent 11351158 Rifabutin treatment methods, uses, and compositions	Patent 11351158 was granted and assigned to BioVersys AG on June, 2022 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	11351158	June 7, 2022
	‌ US Patent 10934295 Antimicrobials and methods of making and using same	Patent 10934295 was granted and assigned to BioVersys AG on March, 2021 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	10934295	March 2, 2021
	‌ US Patent 10815237 Antimicrobials and methods of making and using same	Patent 10815237 was granted and assigned to BioVersys AG on October, 2020 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	10815237	October 27, 2020
	‌ US Patent 8912329 Composition for treatment of tuberculosis	Patent 8912329 was granted and assigned to BioVersys AG on December, 2014 by the United States Patent and Trademark Office.		BioVersys AG		United States Patent and Trademark Office	8912329	December 16, 2014
	‌ US Patent 10815238 Antimicrobial compounds and methods of making and using the same	Patent 10815238 was granted and assigned to BioVersys AG on October, 2020 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	10815238	October 27, 2020
	‌ US Patent 11999739 Antimicrobials methods of making and using the same	Patent 11999739 was granted and assigned to BioVersys AG on June, 2024 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	11999739	June 4, 2024
	‌ US Patent 11833139 Rifabutin treatment methods, uses, and compositions	Patent 11833139 was granted and assigned to BioVersys AG on December, 2023 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	11833139	December 5, 2023
	‌ US Patent 11903934 Rifabutin treatment methods, uses, and compositions	Patent 11903934 was granted and assigned to BioVersys AG on February, 2024 by the United States Patent and Trademark Office.	BioVersys AG	BioVersys AG		United States Patent and Trademark Office	11903934	February 20, 2024

13 results

0 selected

13 results

0 selected